41 search results found

  • Cracking Cancer 2.0 - Lightning Talks

    December 7, 2017 | Startup Exchange Video | Duration: 30:6

    Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.

  • Past Deadline: Aug 31, 2023

    JIMCO Technology & JIMCO Life Sciences seek startups working across sectors

    partnership

    Early-stage backers of Rivian, JIMCO seeks MIT spin-off startups that are initiating or improving commercialization efforts across multiple industries - eg. energy, water, mobility.

  • Tue, July 16, 2024 | Conference

    2024 MIT Tokyo Life Science Symposium - Startup Exchange Lightning Talks

    Tokyo, Japan

    Startup Lightning Talks presented at the 2024 MIT Tokyo Life Science Symposium.

     

     

  • Past Deadline: Mar 26, 2021

    P&G Seeks Startups in Driving Responsible and Lasting Behavior Change

    partnership

    P&G is looking for new technology-enabled solutions, services and business models that incentivize and drive lasting behavior change.

  • Asimov, Inc.

    Cambridge, Massachusetts
    Biotechnology
    Asimov's technology is a synthetic biology CAD platform (Cello) that we developed at MIT to program living cells with "genetic circuits". We have used it to design the most complex sense-and-response cell behaviors to date. We are now extending the platform to build genetic control modules for cell... More

  • Immunai

    New York, NY
    Immunai is an end-to-end computational immunology company leveraging the power of single-cell biology and AI to decode the Immune System to improve health and accelerate therapeutics.
    Keywords:
    single-cell sequencing, single-cell genomics, machine learning, Artificial Intelligence

  • Stratagen Bio

    Cambridge, MA
    Biotechnology
    Tumor hypoxia is characterized by extremely low levels of oxygen (<15.2 mmHg/2% O2). It occurs in fifty percent1 of all tumors and is a well-established negative prognostic indicator. Poor outcomes are seen in patients with hypoxic tumors in cancers including breast, cervical, head and neck, soft... More
    Keywords:
    Oxygen Sensing, Magnetic Resonance Imaging, Image-Guided Therapies, personalized medicine

  • Vaxess Technologies, Inc.

    Cambridge, MA
    Biotechnology
    Vaxess Technologies is a venture-backed biotechnology company developing novel products based on its proprietary MIMIX microneedle delivery platform. Our lead program is a sustain-release flu microneedle patch. We also have a pipeline of undisclosed targets including mRNA, immun/ooncology and other... More

  • Cracking Cancer 2.0 - Industry/MIT Moment

    December 7, 2017 | Startup Exchange Video | Duration: 2:46

    Erik Vogan, PhD, MBA, Program Director, MIT Corporate Relations Industrial Liaison Program

  • Past Deadline: Feb 5, 2021

    P&G seeks startups for innovative consumer experience

    other

    P&G is seeking startups for innovative consumer experiences: 1) Making a Sustainable Lifestyle Effortless 2) AI Technologies for Digital Expert Advisors with conversational AI and hybrid human-ML,  3) Transformative Transactions including sourcing, manufacturing, distribution, and autonomous supply chain, 4) Automation of Daily In-Home Consumer Tasks, and 5) Enabling Breakthrough Growth for Omnichannel Brands.